Source: DGNews | Posted 8 years ago
FDA Advisory Committee Recommends Arava (Leflunomide) For Improvement In Physical Function In Rheumatoid Arthritis
Tags:
Committee Also Confirms the Safety Profile of Arava
STRASBOURG, FRANCE -- March 6, 2003 -- Aventis announced that the Arthritis Advisory Committee of the U.S. Food and Drug Administration (FDA) voted to recommend approval of an expanded indication for Arava
Comments